AU2002366544A1 - Adjuvant formulations for bacterial and virus vaccines and method of making same - Google Patents

Adjuvant formulations for bacterial and virus vaccines and method of making same

Info

Publication number
AU2002366544A1
AU2002366544A1 AU2002366544A AU2002366544A AU2002366544A1 AU 2002366544 A1 AU2002366544 A1 AU 2002366544A1 AU 2002366544 A AU2002366544 A AU 2002366544A AU 2002366544 A AU2002366544 A AU 2002366544A AU 2002366544 A1 AU2002366544 A1 AU 2002366544A1
Authority
AU
Australia
Prior art keywords
bacterial
making same
virus vaccines
adjuvant formulations
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366544A
Other versions
AU2002366544A8 (en
Inventor
John Hadden
Paul H. Naylor
Kathy L. Signorelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuno-Rx Inc
Original Assignee
Immuno-Rx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno-Rx Inc filed Critical Immuno-Rx Inc
Publication of AU2002366544A8 publication Critical patent/AU2002366544A8/en
Publication of AU2002366544A1 publication Critical patent/AU2002366544A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002366544A 2001-07-27 2002-07-26 Adjuvant formulations for bacterial and virus vaccines and method of making same Abandoned AU2002366544A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30813901P 2001-07-27 2001-07-27
US60/308,139 2001-07-27
PCT/US2002/023765 WO2003049670A2 (en) 2001-07-27 2002-07-26 Adjuvant formulations for bacterial and virus vaccines and method of making same

Publications (2)

Publication Number Publication Date
AU2002366544A8 AU2002366544A8 (en) 2003-06-23
AU2002366544A1 true AU2002366544A1 (en) 2003-06-23

Family

ID=23192713

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366544A Abandoned AU2002366544A1 (en) 2001-07-27 2002-07-26 Adjuvant formulations for bacterial and virus vaccines and method of making same

Country Status (5)

Country Link
US (2) US20050148538A1 (en)
EP (1) EP1465639A4 (en)
AU (1) AU2002366544A1 (en)
CA (1) CA2493444A1 (en)
WO (1) WO2003049670A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004253862B2 (en) * 2003-04-29 2010-05-27 Irx Therapeutics, Inc. Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
BRPI0414045A (en) 2003-09-05 2006-10-24 Anadys Pharmaceuticals Inc administration of tlr7 ligands and prodrugs thereof for the treatment of hepatitis C virus infection
WO2005086637A2 (en) 2004-02-11 2005-09-22 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
AU2005242409A1 (en) * 2004-05-19 2005-11-24 Alza Corporation Method and formulation for transdermal delivery of immunologically active agents
US7858073B2 (en) * 2004-08-17 2010-12-28 Hunter Technology Limited Oral killed vaccines and method for providing same
GB201105981D0 (en) * 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
WO2014096958A1 (en) 2012-11-02 2014-06-26 Academisch Medisch Centrum Inosine monophosphate and salts thereof for use in the treatment of complement-related disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
CA2675757C (en) * 1995-04-21 2011-03-15 University Of South Florida Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof

Also Published As

Publication number Publication date
US20050148538A1 (en) 2005-07-07
WO2003049670A2 (en) 2003-06-19
EP1465639A4 (en) 2006-05-24
WO2003049670A3 (en) 2003-11-06
AU2002366544A8 (en) 2003-06-23
EP1465639A2 (en) 2004-10-13
US20130171192A1 (en) 2013-07-04
CA2493444A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
EP1357938B8 (en) Hyperblebbing bacterial strains and use thereof for production of vaccines
AU2001255196A1 (en) Compositions and methods for enhancing immunogenicity of antigens
AU2002348319A1 (en) Toneable conduit and method of preparing same
AU2002329915A1 (en) Methods for sterilizing preparations of digestive enzymes
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AU2002360473A1 (en) Method for preparation of three-demensional bodies
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2002306577A1 (en) Targeting system and method of targeting
AU2003270779A1 (en) Vaccine compositions and adjuvant
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
AU2002335815A1 (en) High-concentration protein formulations and method of manufacture
AU2003259374A1 (en) Vaccine comprising il-13 and an adjuvant
AU2002258979A1 (en) Method of preparing and formulations including hydrolyzed jojoba protein
AU2002366544A1 (en) Adjuvant formulations for bacterial and virus vaccines and method of making same
AU2003278175A1 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AU2001290834A1 (en) System and method for computerized ordering of vaccines
AU2002324753A1 (en) Composition and method for treating viral infection
EP1578723A3 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2002367959A1 (en) Process for the preparation of oxazolidinones and method of use thereof
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2002347464A1 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2002217820A1 (en) Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
AU2002364696A1 (en) Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
AU2001256675A1 (en) Method of preparing virus vector

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase